Indatens (Indapamide Hemihydrate)

Indapamide blocks sodium‑chloride reabsorption in the distal convoluted tubule of the kidney, increasing the excretion of sodium and water. This diuretic effect lowers blood volume and peripheral vascular resistance, helping to control blood pressure and diminish edema.

The specific dose of Indatens is determined by the prescribing clinician based on the patient’s condition, response, and renal function. Dosage adjustments are made according to individual therapeutic needs and laboratory monitoring.

Indapamide is generally classified as contraindicated in pregnancy unless the potential benefit outweighs the risk, and it is not recommended while breastfeeding because it may pass into breast milk. Physicians should evaluate risks before prescribing to pregnant or lactating women.

To request Indatens, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Indapamide belongs to the thiazide‑like diuretic class, offering both diuretic and vasodilatory actions. Compared with pure thiazide diuretics, it may have a longer duration and a more favorable metabolic profile, while other classes such as ACE inhibitors or calcium‑channel blockers act via different mechanisms.

Indatens should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain stability and potency.

Indatens is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and any dietary considerations.

Serious risks include severe dehydration, marked electrolyte disturbances such as profound hypokalemia or hyponatremia, and allergic reactions that may present as rash, itching, or angioedema. Prompt medical evaluation is required if any of these symptoms occur.

Indapamide is contraindicated in patients with anuria (no urine output), severe renal impairment, or known hypersensitivity to indapamide or related sulfonamide compounds. Caution is also advised for individuals with uncontrolled diabetes, gout, or those taking interacting medications.